Results 251 to 260 of about 700,247 (353)
PGI2-Aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction [PDF]
Habazettl, H. +3 more
core +1 more source
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely used for pain and inflammation but are associated with gastrointestinal (GI) bleeding. While this risk is well established, most studies evaluate NSAIDs as a homogenous class, limiting clinical decision‐making based on individual agent safety.
Abdelrahman G. Tawfik +7 more
wiley +1 more source
Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach. [PDF]
Kaur J, Kaur G, Kaur C, Kumar S.
europepmc +1 more source
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum +10 more
wiley +1 more source
TBX4 in Pulmonary Hypertension: Linking Lung Development to Precision Therapy. [PDF]
El Khoury W, Chan SY.
europepmc +1 more source
Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami +2 more
wiley +1 more source
The Emergence of Oral Sildenafil for Pulmonary Hypertension Management. [PDF]
Butrous G.
europepmc +1 more source
ABSTRACT Anticipating the evolution of septic patients with community‐acquired pneumonia (CAP) is challenging for front‐line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but also immune status.
Thomas Lafon +4 more
wiley +1 more source
Porto-Pulmonary Hypertension in Children: Insights From a National Registry. [PDF]
Quyam S, Baker A, Calder A, Moledina S.
europepmc +1 more source

